Landscapes / Companies
OBI Pharma, Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 7 in all
Trials
4 active
8 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | — | |||
| Also tested for | Triple Negative Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2027Phase 1/2 trial completes | |||
| Next date | Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | 8 Feb 2029Phase 1/2 trial completes | |||
| Next date | 8 Feb 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
OBI-833/OBI-821not checked |
— |
Phase 2 | — | ||
| Also tested for | Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021